The perfusion tubing systems market is projected to register a CAGR of 3.4% during the forecast period, up from US$ 1.2 Bn in 2021 to reach a valuation of US$ 1.74 Billlion by 2032.
The perfusion tubing systems market is anticipated to show promising growth prospects during the forecast period as a result of growing competition. New competitors are offering a variety of options at reasonable pricing to fulfil the demand for perfusion tubing systems making them more accessible to customers in the global perfusion tubing systems market.
A pump tubing system is a new technology that is utilised in conjunction with catheters in diagnostic equipment. The launch of innovative diagnostic treatments for hollow organs is projected to drive the sales of perfusion tubing systems exponentially. Pressure measurement tubing can withstand the high pressure of fluids used during surgery, which may increase the demand for perfusion tubing systems in the future.
| Report Attribute | Details |
| Estimated Base Year Value (2021) | US$ 1.2 Billion |
| Expected Market Value (2022) | US$ 1.25 Billion |
| Anticipated Forecast Value (2032) | US$ 1.74 Billion |
| Projected Growth Rate (2022-2032) | 3.4% CAGR |
Sales of perfusion tubing systems are expected to rise significantly. In addition to this, demand for perfusion tubing systems is rising on account of US$ 1.4 Bn by 2026. Increasing sales of perfusion tubing systems are also projected to contribute to the growth of the perfusion tubing systems market share.
Manufacturers in the perfusion tubing systems market get a big platform from which to serve the whole demand for perfusion tubing systems. The worldwide perfusion tubing systems market is seeing increased competition. With growing competition, new competitors are offering a variety of options at reasonable pricing, fulfilling the demand for perfusion tubing systems more accessible to customers.
The perfusion tubing systems market share is predicted to expand at a rapid pace during the forecast period, owing to the increasing incidence of lung cancer and cardiac surgery. According to method type, infusion set tubing is expected to generate the most sales of perfusion tubing systems throughout the projection period, owing to advancements in perfusion techniques for cardiac and pulmonary therapy.
According to treatment type, the heart and bronchial musculature therapy market is predicted to expand sales of perfusion tubing systems rapidly due to rising rates of heart attack and lung cancer. Hospitals will continue to lead the perfusion tubing systems market share in terms of revenue, followed by specialist clinics. While the medical research centre sector of the perfusion tubing systems market is predicted to develop faster than the other end-user segments during the forecast period.
LABORIE, Medtronic Perfusion Systems, Biorep technologies, Nipro, Luigs & Neumann, Bioptechs, inc. Innosets, XVIVO Perfusion, AlkorDraka Group, Spirax-Sarco Engineering Company, and Warner Instruments are some of the leading participants in theperfusion tubing systems market.
The rising prevalence of chronic illnesses such as heart disease, renal failure, and liver disease may need organ transplantation. Organ transplantation may stimulate the demand for perfusion tubing systems. However, altering lifestyle habits such as smoking and alcohol intake may result in heart failure and liver disorders; hence, treating these diseases is projected to boost the sales of perfusion tubing systemsin the future.
Introducing a bio plasticizer with low toxicity and a lower-cost perfusion tubing set might improve the sales of perfusion tubing systems. Strict rules and restrictions imposed by regional regulatory agencies are the primary impediments to the demand for perfusion tubing systems.
Rapid advancements in disease detection procedures for chronic disorders are projected to fuel the sales of perfusion tubing systems in the coming years. The primary problem for perfusion tubing systems market producers is sterility maintenance.
The migration of di(2-Ethylhexyl)phthalate plasticizer (DEHP) from polyvinyl chloride (PVC) circuit tubing may have adverse effects on the body, so deterring the lower expansion in sales of perfusion tubing systems. Maintaining the quality of plasticizers is a significant problem for manufacturers while making perfusion tubing sets, which may impact the perfusion tubing systems marketgrowing slowly.
On a regional level, the North American market for sales of perfusion tubing systems is expected to rise at a rapid pace during the projected period. Because the rate of internal body organ surgery is increasing and the technology for organ transplantation is advancing, the perfusion tubing systems market is expected to grow in the future.
Europe is predicted to be the second-largest market throughout the projection period, with a growing demand for perfusion tubing systems in the future. At the moment, there is a lucrative potential for manufacturers of perfusion tubing systems market in the Asia Pacific, India, due to the rising demand for perfusion tubing systems.
Latin America and EMEA markets in terms of revenue sales of perfusion tubing systems may have moderate growth rates due to poor public knowledge of organ transplantation techniques and ethical issues surrounding organ donation. As a result, these areas are likely to have significant revenue growth from the perfusion tubing systems market share throughout the projection period.
LABORIE, Medtronic Perfusion Systems, Biorep technologies, Nipro, Luigs & Neumann, Bioptechs, inc. Innosets, XVIVO Perfusion, AlkorDraka Group, Spirax-Sarco Engineering Company, and Warner Instruments are some of the leading participants in the perfusion tubing systems market.
| Report Attribute | Details |
| Growth rate | CAGR of 3.4% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2014 – 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Component Type, Application, End Users, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | LABORIE, Medtronic Perfusion Systems, Biorep technologies, Nipro, Luigs & Neumann, Bioptechs, inc. Innosets, XVIVO Perfusion, AlkorDraka Group, Spirax-Sarco Engineering Company, Warner Instruments |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail of customized purchase options to meet your exact research needs. |
By Component Type:
By Application:
By End User:
By Region:
The perfusion tubing systems market is forecasted to register a CAGR of 3.4% during the forecast period.
Key players holding substantial perfusion tubing systems market include LABORIE, Medtronic Perfusion Systems, Biorep technologies, Nipro and many more.
As per the analysis, the perfusion tubing systems market share is likely to be US$ 1.4 Bn by 2026.
Demand for perfusion tubing systems is likely to rise owing to the increasing incidence of lung cancer and cardiac surgery. According to method type, infusion set tubing is expected to generate the most sales of perfusion tubing systems throughout the projection period
Explore Similar Insights
Perfusion Tubing Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
